SEC Form 4Coverage since Dec 27, 2024
$RANI insider trading
Over the last 12 months, Rani Therapeutics Holdings insiders reported 2 buys totaling $50K and 1 sale totaling $301 across SEC Form 4 filings.
- Bought · 12m
- $50K 2 events
- Sold · 12m
- $301 1 event
- Events · 12m
- 3 Form 4 filings, grouped
- Insiders · 12m
- 3 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $RANI · 12Mvia TradingView
Top insiders · 12m
Imran TalatChief Executive Officer1× · $25K
IMRAN MIR A—1× · $25K
Javadi AlirezaChief Technical Officer1× · $301
All insider trades
4 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | IMRAN MIR AD·10% | ▲ Buy | 36,000 | $0.69 | $25K | +1.7% | — |
| Jul 17, 2026 | Imran TalatChief Executive Officer · O·D | ▲ Buy | 35,000 | $0.72 | $25K | +8.1% | — |
| Mar 27, 2026 | Javadi AlirezaChief Technical Officer · O | ▼ Sale | 386 | $0.78 | $301 | -3.8% | late |
| Dec 27, 2024 | Imran TalatChief Executive Officer · O·D | ▼ Sale | 8,014 | $1.41 | $11K | -1.6% | late |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $RANI feed.